CCTV News: The National Health Insurance Administration of China announced the 2024 statistical report on the development of medical insurance in 2024, including insurance participation, medical treatment in other places, drug consumption procurement, maternity insurance and other contents. In 2024, the basic medical insurance participation rate will be stable at 95%, and the medical insurance fund will achieve a surplus of more than 510 billion yuan this year, and the revenue and expenditure situation will be stable.

According to the express report, 1326.3783 million people participated in the basic medical insurance in 2024, the quality of insurance participation continued to improve, the insurance structure was further optimized, and the insurance rate was consolidated at 95%. The insurance coverage rate of low-income and people who have been lifted out of poverty is stable at more than 99%. 25 provinces that undertake the original poverty alleviation task have funded 86.23 million insured people.

The total revenue of the medical insurance fund in 2024 was 3.48 trillion yuan and the total expenditure was 2.97 trillion yuan, and the surplus of more than 510 billion yuan was achieved during the year. The revenue and expenditure situation were stable. Both the employee medical insurance and the resident medical insurance coordinated funds achieved during the year. In 2024, the demand for outpatient medical treatment continued to be released rapidly and significantly increased, and the number of employees and residents who enjoyed treatment in outpatient clinics exceeded 3 billion.

Zhang Chenguang, deputy director of the Department of Regulation, Finance and Regulations of the National Medical Insurance Administration, said: "my country's nearly 3 trillion yuan of medical insurance fund expenditure has tightly strengthened the medical insurance network of nearly 1.33 billion insured persons with a proportion of only 2.2% of GDP. The cumulative balance of the 3.8 trillion yuan of unified fund is a solid support for everyone to seek medical treatment."

According to the express report, 91 new types of drug catalog adjustments in 2024, reaching 3,159 types; the number of people who directly settled hospitalizations for medical treatment across provinces increased by 27.37%, and the number of people who went outpatients increased by 90.18%, and the number of people who went outpatients to treat medical treatment across provinces increased from 5 to 10 types. In the seven years since the establishment of the National Health Insurance Administration, the cumulative expenditure of medical insurance funds has exceeded 16.5 trillion yuan, with an average annual growth rate of 11%.

In 2024, centralized procurement of drugs and consumables continued to expand, from Western medicine and chemical medicine to Chinese patent medicine and Chinese herbal medicines; consumables centralized procurement of two types have been added.

The time for innovative drugs from marketing to inclusion in medical insurance was greatly shortened. During the 2018-2024 new drug agreement period, sales revenue exceeded 540 billion yuan, of which the medical insurance fund expenditure exceeded 370 billion yuan.